User profiles for Houda Bahig

Houda Bahig

Centre Hospitalier de l'Universite de Montreal
Verified email at ssss.gouv.qc.ca
Cited by 1934

[HTML][HTML] Spatially fractionated radiation therapy: History, present and the future

…, J Fan, E Gressen, X Zhang, CL Limoli, H Bahig… - Clinical and translational …, 2020 - Elsevier
Spatially Fractionated Radiation therapy (SFRT) has a history of over 100 years. The principle
of SFRT is distinctive from the standard radiation approaches, as it treats the total tumor …

SUNSET: Stereotactic radiation for ultracentral non–small-cell lung cancer—A safety and efficacy trial

M Giuliani, AS Mathew, H Bahig, SV Bratman, E Filion… - Clinical lung cancer, 2018 - Elsevier
Background Lung stereotactic body radiotherapy (SBRT) is considered a standard curative
treatment for medically inoperable early stage non–small-cell lung cancer (NSCLC). Patients …

Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease

H Bahig, E Filion, T Vu, J Chalaoui, L Lambert… - Practical radiation …, 2016 - Elsevier
Purpose To investigate the incidence and predictive factors of severe radiation pneumonitis
(RP) after stereotactic ablative radiation therapy (SABR) in early-stage lung cancer patients …

[HTML][HTML] Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell …

…, PA Bradbury, G Liu, FA Shepherd, H Bahig… - European Journal of …, 2021 - Elsevier
Background The PACIFIC trial demonstrated that durvalumab therapy following chemoradiation
(CRT) was associated with improved overall survival (OS) in patients with stage III non–…

The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review

…, TP Del Socorro, M Chamaillard, H Bahig… - Radiotherapy and …, 2021 - Elsevier
Radiation therapy (RT) is an essential component of therapy either curative or palliative
armamentarium in oncology, but its efficacy varies considerably among patients through many …

Predictive parameters of CyberKnife fiducial-less (XSight Lung) applicability for treatment of early non-small cell lung cancer: a single-center experience

H Bahig, MP Campeau, T Vu, R Doucet… - International Journal of …, 2013 - Elsevier
Purpose To determine which parameters allow for CyberKnife fiducial-less tumor tracking in
stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer. …

[HTML][HTML] Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for …

…, DP Goldstein, A Eskander, Z Husain, H Bahig… - BMC cancer, 2020 - Springer
Background Patients with human papillomavirus-positive (HPV+) oropharyngeal squamous
cell carcinoma (OPC) have substantially better treatment response and overall survival (OS) …

Oligometastases: emerging evidence

W Liu, H Bahig, DA Palma - Journal of Clinical Oncology, 2022 - ingentaconnect.com
The hypothesis that ablative therapies (such as surgery or radiation) can be used to cure
patients with a limited number of metastases was influential in changing practice. Early …

[HTML][HTML] Radiomics feature stability of open-source software evaluated on apparent diffusion coefficient maps in head and neck cancer

…, C Cardenas, N Hardcastle, T Kron, J Wang, H Bahig… - Scientific reports, 2021 - nature.com
Radiomics is a promising technique for discovering image based biomarkers of therapy
response in cancer. Reproducibility of radiomics features is a known issue that is addressed by …

Current therapy for metastatic head and neck cancer: evidence, opportunities, and challenges

TM Wise-Draper, H Bahig, M Tonneau… - American Society of …, 2022 - ascopubs.org
Management of metastatic head and neck squamous cell carcinoma is evolving as new
systemic therapies have led to improvements in survival, and as advances in locoregional …